Norbert Minet

Norbert Minet

Auto-generated profile, based on publicly available information

Norbert Minet

Laboratory of Lymphocyte Activation and Susceptibility To EBV Infection, Inserm UMR 1163, Institut Imagine, Paris, France

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
EMEmmanuel Martin
Emmanuel Martin
NMNorbert Minet
Norbert Minet
ABAnne-Claire Boschat
Anne-Claire Boschat
SSSylvia Sanquer
Sylvia Sanquer
SSSteicy Sobrino
Steicy Sobrino
SLSylvain Latour
Sylvain Latour
Cytidine triphosphate (CTP) synthetase 1 (CTPS1) deficiency is caused by a unique homozygous frameshift splice mutation (c.1692-1G>C, p.T566Dfs26X). CTPS1-deficient patients display severe bacterial and viral infections. CTPS1 is responsible for CTP nucleotide de novo production involved in DNA/RNA synthesis. Herein, we characterized in depth lymphocyte defects associated with CTPS1 deficiency. Immune phenotyping performed in 7 patients showed absence or low numbers of mucosal-associated T cells, invariant NKT cells, memory B cells, and NK cells, whereas other subsets were normal. Proliferation and IL-2 secretion by T cells in response to TCR activation were markedly decreased in all patients, while other T cell effector functions were preserved. The CTPS1 T566Dfs26X mutant protein was found to be hypomorphic, resulting in 80%–90% reduction of protein expression and CTPS activity in cells of patients. Inactivation of CTPS1 in a T cell leukemia fully abolished cell proliferation. Expression of CTPS1 T566Dfs26X failed to restore proliferation of CTPS1-deficient leukemia cells to normal, except when forcing its expression to a level comparable to that of WT CTPS1. This indicates that CTPS1 T566Dfs26X retained normal CTPS activity, and thus the loss of function of CTPS1 T566Dfs26X is completely attributable to protein instability. This study supports that CTPS1 represents an attractive therapeutic target to selectively inhibit pathological T cell proliferation, including lymphoma.

1 January 2014 in Vascular Cell
Verified
Journal Article
Open access
PDF file
ELEsma Lejmi
Esma Lejmi
IBIlyes Bouras
Ilyes Bouras
SCSerge Camelo
Serge Camelo
MRMarie Roumieux
Marie Roumieux
NMNorbert Minet
Norbert Minet
LLLaurence Leconte
Laurence Leconte
Netrins are secreted molecules involved in axon guidance and angiogenesis. We previously showed that Netrin-4 acts as an anti-angiogenic factor by inhibiting endothelial cell (EC) functions. In this study, we investigated the effects of Netrin-4 on vascular smooth muscle cell (VSMC) activity in vitroand in vivo. We show that exogenous Netrin-4 stimulated VSMC adhesion and migration, and increased their coverage on EC tubes (grown on a Matrigel substrate). siRNA knock-down of endogenous Netrin-4 expression in VSMC decreased their recruitment to EC tubes. VSMC expressed Netrin-4 and three of the six Netrin-1 cognate receptors: DCC, Neogenin, and Unc5B. Silencing of these receptors reduced Netrin-4 adhesion to VSMC, strongly suggesting that these receptors were involved in the recruitment process. We previously showed that Netrin-4 overexpression in PC3 cancer cells delayed tumor growth in a model of subcutaneous xenograft by reducing tumor vessel density. Here, we show that Netrin-4 overexpression improved tumor blood vessel structure and increased VSMC coverage. Thus, Netrin-4 induced mural cell recruitment may play a role in the inhibition of tumor growth. Our data suggest that Netrin-4 is important for blood vessel normalization through the regulation of both endothelial and perivascular cells.

22 June 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
NMNorbert Minet
Norbert Minet
ABAnne-Claire Boschat
Anne-Claire Boschat
RLRebecca Lane
Rebecca Lane
DLDavid Laughton
David Laughton
PBPhilip Beer
Philip Beer
SLSylvain Latour
Sylvain Latour
The CTP nucleotide is a key precursor of nucleic acids metabolism essential for DNA replication. De novo CTP production relies on CTP synthetases 1 and 2 (CTPS1 and CTPS2) that catalyze the conversion of UTP into CTP. CTP synthetase activity is high in proliferating cells including cancer cells; however, the respective roles of CTPS1 and CTPS2 in cell proliferation are not known. By inactivation ofCTPS1and/orCTPS2and complementation experiments, we showed that both CTPS1 and CTPS2 are differentially required for cell proliferation. CTPS1 was more efficient in promoting proliferation than CTPS2, in association with a higher intrinsic enzymatic activity that was more resistant to inhibition by 3-deaza-uridine, an UTP analog. The contribution of CTPS2 to cell proliferation was modest when CTPS1 was expressed but essential in absence of CTPS1. Public databases analysis of more than 1,000 inactivated cancer cell lines for CTPS1 or CTPS2 confirmed that cell growth is highly dependent of CTPS1 but less or not of CTPS2. Therefore, our results demonstrate that CTPS1 is the main contributor to cell proliferation.

4 March 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSClaire Soudais
Claire Soudais
RSRomane Schaus
Romane Schaus
CBCamille Bachelet
Camille Bachelet
NMNorbert Minet
Norbert Minet
SMSara Mouasni
Sara Mouasni
SLSylvain Latour
Sylvain Latour
De novo synthesis of the pyrimidine, cytidine triphosphate (CTP), is crucial for DNA/RNA metabolism and depends on the CTP synthetases, CTPS1 and −2. Partial CTPS1 deficiency in humans has previously been shown to lead to immunodeficiency, with impaired expansion of T and B cells. Here, we examine the effects of conditional and inducible inactivation of Ctps1 and/or Ctps2 on mouse embryonic development and immunity. We report that deletion of Ctps1 , but not Ctps2 , is embryonic-lethal. Tissue and cells with high proliferation and renewal rates, such as intestinal epithelium, erythroid and thymic lineages, activated B and T lymphocytes, and memory T cells strongly rely on CTPS1 for their maintenance and growth. However, both CTPS1 and CTPS2 are required for T cell proliferation following TCR stimulation. Deletion of Ctps1 in T cells or treatment with a CTPS1 inhibitor rescued Foxp3 -deficient mice from fatal systemic autoimmunity and reduced the severity of experimental autoimmune encephalomyelitis. These findings support that CTPS1 may represent a target for immune suppression.

16 September 2019 in Journal of Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
ABAnne‐Claire Boschat
Anne‐Claire Boschat
NMNorbert Minet
Norbert Minet
EMEmmanuel Martin
Emmanuel Martin
RBRobert Barouki
Robert Barouki
SLSylvain Latour
Sylvain Latour
SSSylvia Sanquer
Sylvia Sanquer

19 December 2025 in Nature Communications
Verified
Journal Article
Open access
CSClaire Soudais
Claire Soudais
RSRomane Schaus
Romane Schaus
CBCamille Bachelet
Camille Bachelet
NMNorbert Minet
Norbert Minet
SMSara Mouasni
Sara Mouasni
SLSylvain Latour
Sylvain Latour